Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001664281-26-000004

Director sold 155,255 shares at an average $6.95 ($1,078,937)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PARMAR KUSH Director 2026-08-06 Sale −10,494 $7.00 $73,458 2,836,098 I: show line 1 in the form
PARMAR KUSH Director 2026-08-07 Sale −52,317 $6.85 $358,371 2,783,781 I: show line 2 in the form
PARMAR KUSH Director 2026-08-10 Sale −92,444 $7.00 $647,108 2,691,337 I: show line 3 in the form
Open-market sales · 155,255 sh · avg $6.95 · $1,078,937
Loading xslF345X06/form4-08102026_110836.xml…